Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
These guys are slow updating shareholders and others, incredible! Changes in management team and BOD indicate there's a lot happening behind the curtain. The dividend agreement (see latest form 8K/A) for the 3 founders tells me they expect rapidly increasing revenues, maybe they signed up a few big partner. Something's happening here.........
it will be fine to the mooooon
A price increase of 30% with a dollar volume of no more than $176. The company is really screwed.
InnovaQor Inc:
- full suite of healthcare modules
- about to launch a "communication network for healthcare professionals" (very promising)
- fully SEC reporting company
- received funding (see latest 10Q), not yet communicated
- expanded the Board and appointed new CEO
- next phase is about increasing revenue
- founders (Lagan, Hollis, Doherty) are entitled to receive dividends based on revenue growth
Also Board expanded with new experienced officials
INQR appointed a new CEO, see latest From 8K/A
Also from the latest 10Q (already communicated on form 8K):
Note 14 – Subsequent Events
On May 12, 2023, the Company authorized 500 shares of Series D Non-Convertible Preferred Stock with a par value of $0.0001 and a stated value of $100. The Company issued 300 shares of Preferred D stock to three subscribers on May 12, 2023, for a total consideration of $30,000. The Preferred D Stock does not have voting rights but each holder of issued and outstanding Series D Preferred Stock shall be entitled to receive monthly as a dividend, an amount equal to (a) the sum of:
* (i) five percent (5%) of the amount of gross sales in excess of $500,000 collected by the Company or any subsidiary (on a consolidated basis) in the ordinary course of business during the month immediately preceding the month in which such dividend becomes payable, which amount shall not exceed $25,000,
* (ii) ten percent (10%) of the amount of gross sales in excess of $1 million collected by the Company or any subsidiary (on a consolidated basis) in the ordinary course of business during the month immediately preceding the month in which such dividend becomes payable which amount shall not exceed $100,000 and
* (iii) two and one-half percent (2.5%) of the amount of gross sales in excess of $2 million collected by the Company or any subsidiary (on a consolidated basis) in the ordinary course of business during the month immediately preceding the month in which such dividend becomes payable.
Of course, this could be bullshit, BUT they're working on this social media platform for healthcare professionals using their proprietary Artificial Intelligence and it seems they're very optimistic about it. Let's wait and see. Some developments I like very much, especially getting fully SEC reporting with audited financials (OTCQB when SP> .01), but revenue growth is what it's all about.
In the 10Q that was filed a few days ago (page 17):
Note 11 – Commitments and Contingencies
Consulting Agreement – the Company entered into a consulting agreement effective June 1, 2021, with a company owned by Mr. Dab, the Company’s former CEO, for a period of one year to provide assistance in developing the Company’s business including communications with existing shareholders and the general public. This company shall be paid $60,000 upon receipt of funding from an outside source or within 90 days of signing the agreement. The $60,000 has been paid subsequent to March 31, 2023. On June 1, 2022, the agreement was extended for another year. The Company continues to owe the amounts provided for in the original agreement and the new agreement increases the monthly fee from $3,500 to $4,500.
Funding is in place! Also former parent company expects to get their huge loan in $INQR back soon and expects a great return on their investment.
Eens kijken.
Nu gaat het goedkomen. (:> ))
On May 14, 2023, Epizon Limited, as the holder of all of the outstanding shares of Series A-1 Preferred Stock, representing 51% of the votes entitled to be cast at a meeting of the stockholders of the Company or to vote by written consent, voted by written consent that the following persons be elected as directors of the Company:
Gerard Dab
Justin Doherty
Francisco Roca, III
Prior to the written consent by Epizon Limited, the members of the Board of Directors were Gerard Dab, Justin Doherty and Sharon Hollis.
Thereafter, also on May 14, 2023, the Board of Directors, by unanimous written consent, (i) elected Gerad Dab as Chairman of the Board and Secretary of the Company; (ii) expanded the size of the Board to four members; (iii) elected Darrell Peterson as a director to fill the vacancy; and (iv) named Mr. Peterson to be Interim President and Chief Executive Officer of the Company. Mr. Peterson will receive a salary at the rate of $10,000 a month.
Mr. Peterson, 64, has had an extensive career in initiating and re-organizing private and public companies serving in capacities ranging from Chief Executive Officer, Chief Financial Officer and consultant. Since January 2021, Mr. Peterson has been CEO and CFO of Galenfeha, Inc., which is a consulting firm for small cap companies. He served as Chief Financial Officer of Nexgen Enterprises, Inc. from October 2018 to October 2022. Nexgen is a combination of closely-held companies. Mr. Peterson assisted in developing accounting systems for each of the companies, including land surveying, the number two mortgage survey company in the State of Florida at the time, automotive services, real estate acquisition, oil field services and logistics. He also headed all legal and tax services during that period. Starting in late 2018, Nexgen grew from $4.5 million to $14.9 million in 2022. Mr. Peterson holds a degree in accounting from Long Island University and started his career with the then Big 8 firm Peat Marwick, now KPMG.
Mr. Roca, 57, has founded and operated a number of businesses in the healthcare industry over the last 20 years, after previously spending 11 years working in the Public Defender’s Office of the 15th Judicial Circuit of Florida. His healthcare businesses have included MRI centers and durable medical equipment providers. Mr. Roca was a founder and Vice President of Sales of Medytox Solutions, Inc., the predecessor business of Rennova Health, Inc., from which the businesses of the Company evolved. At Medtox, he created and oversaw a sales team that grew revenues from under $1 million a year in 2011 to 2012 to in excess of $50 million in 2014. Prior to Medytox, Mr. Roca was the owner and Chief Marketing Officer of Sportscare Orthopedics, Inc., a supplier of orthopedic braces to doctors, clinics and therapists. Mr. Roca holds a Bachelor of Sciences degree from Florida State University.
Link:
https://www.otcmarkets.com/filing/html?id=16667282&guid=w3u-kWiGKghJ2Vh
What actually happened to the announced capital increase? Why don't we hear anything more about it? Without fresh capital, there is no investment. Without investment, there is no progress, and there continues to be stagnation.
ouch. awful report. hollis and dab really dont know what they are doing. this stock is doomed
The annual report 2022 was filed yesterday. Not much to be optimistic about. Revenue down, financial position bad, BUT former parent company Renova Health is funding all operations. Meanwhile INQR is building their new integrated platform. INQR needs more time, but Renova seems convinced they will make it in the future.
yeah but it looked better at that than it has in a long time. then it walled up and dropped off again.
Even 005-0075 is a huge spread
Huge spreads sometimes is an indicator of good things to come. Those who are bold enough to buy may be rewarded later. Huge spreads usually prevents early sell offs... But yeah I think a "varmint" did encounter this ticker. :)
it was 005-0075 when i posted it looks crap now yea
Huge spread, some “varmint” probably hit the ask so he could yell about the jump lol
nice little pop here could be ready . a filing showing assets could be bank
Why would a dwarf want to grow when he is already overwhelmed with its current size?
Quote: InnovaQor, Inc. (the “Company”) is unable to file, without unreasonable effort and expense, its Annual Report on Form 10-K for the year ended December 31, 2022 within the prescribed time period because the Company is still compiling information for the Form 10-K and its auditors have not completed their audit of the financial statements for the year then ended. The Company expects to file its Form 10-K on or prior to the fifteenth calendar day following the prescribed due date.
https://www.otcmarkets.com/filing/html?id=16531328&guid=YaA-k65Tb1LtQth
If liquidity is not a problem, why the company itself states that the lower revenues resulted from losing customers that were acquired or went out of business and new customers not being secured because of inability of the company to invest in sales, marketing and delivery or in further development of its products? And why is the company now planning a capital increase?
INQR's predecessor VMCS was shit, never delivered on its promises. But INQR so far did everything right. Audited figures and an upgrade to SEC reporting after filing Form 10Q-12G. They keep us up to date with press releases. We'll know soon enough if they can sell their healthcare modules directly or with help from XCPCNL. Liquidity is not a problem as the former parent company supplies funding. Watch how they manage their business, compare it to shitty MVNT. See the difference?
For a great future, action would first have to follow. Apart from big words, nothing has happened so far.
$INQR Our new platforms will feature intelligent applications using the latest AI and blockchain standards to provide high level automation for increased efficiency. Some $20 M have been invested to create a number of fully developed products and services which we offers through wholly-owned subsidiaries that provide medical support services primarily to clinical laboratories, corporate operations, rural hospitals, physician practices and behavioral health/substance abuse centers.
$INQR Is a fully SEC-reporting company and produces audited figures. Great future!
WEST PALM BEACH, Fla., Sept. 19, 2022 (GLOBE NEWSWIRE) -- InnovaQor, Inc. (OTC: VMCS), today announced the successful onboarding of a new multi-location facility to its Medical Mime EHR (Electronic Health Records) solution.
InnovaQor is pleased to confirm that its subsidiary Medical Mime, Inc. has onboarded a new Montana-based behavioral health client whose three locations will transition from an existing EHR to its Medical Mime solution over a three-month period. All Medical Mime clients pay an implementation fee to facilitate the installation of our EHR and training of staff, and then pay a monthly subscription fee based on the number of users.
WEST PALM BEACH, Fla., Feb. 27, 2023 (GLOBE NEWSWIRE) -- InnovaQor, Inc. (OTC: INQR), Completes Agreement for Brand, Services and Product Marketing
InnovaQor has on February 24 signed an agreement with XCPCNL Business Services Corporation (OTC XCPL) to initiate a sales and marketing strategy for InnovaQor’s healthcare software products and services. XCPCNL will develop a Strategic Sales and Marketing program to meaningfully connect with targeted customers to cultivate the long-term growth and sustainability of the InnovaQor portfolio of services and products.
WEST PALM BEACH, Fla., Feb. 28, 2023 (GLOBE NEWSWIRE) -- InnovaQor, Inc. (OTC: INQR), Subsidiary Launches Automated Billing Solution for customers
InnovaQor subsidiary, Medical Mime, Inc.,?a provider of an EHR (Electronic Health Records) software to behavioral health and substance abuse facilities, today announced the launch of an automated billing solution for use with its EHR software.
more useless news that wont translate to any value . wonderful . keep cranking out that trash
Always just future prospects. Where are the results? https://www.otcmarkets.com/stock/INQR/news/InnovaQor-IncCompletes-Agreement-for-Brand-Services-and-Product-Marketing?id=391333
more worthless news from this stupid company and the incompetent idiots who run it
Where did you see that?
interesting update to otc profile business description ai and blockchain mentions also 20m
Nice move today, hope we go higher and we get some news!
its a pile of crap scam obviously . the team running this shell are all idiots who cant get anything right.
Did the symbol change induce a sell-off, or is the sell-off just because this stock/company is a scam?
They are keeping pink current and float is only 158 million
Time to fly
Rnva will piggy back it
SUMTIN HUGE IS BREWING
I HEARD THAT SEVERSL LARGE DEALS ARE IN THE WORX !!!!’
I May gather another batch of shares
When news hits this is a big one
Lots of travel low float
seems like no matter what they do
this thing is dead
A mere change of name will not bring anything. As long as this Gerard Dab continues to have his fingers in the pie, we can wait until the day of never-never for good news.
After getting Pink Current OTC and sharing the news about a new large client in Montana, it has been very quiet. Probably because they could not build their brand INNOVAQOR as long as FINRA didn't approve the ticker change. Well that's done now. I expect some very good news shortly
very interesting news, maybe it will start .... $$
Looks like everything's according to plan, but it took a long time for FINRA to approve the new symbol. Think we've seen the bottom here. Waiting for news about new clients, will blow the SP above a dime
very interesting. do you think it will run?
VMCS: effective Feb. 14,2023 VisualMED Clinical Solutions Corp., VMCS, will change to InnovaQor Inc., INQR:
https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
InnovaQor is a kind of a pioneer in the domain of creating a social platform for physicians, creating a networking, knowledge sharing, and hiring mechanism along the lines of LinkedIn. There is a global shortfall of 4.3 million doctors, nurses, and other healthcare professionals. Through its platform Curallo.com, InnovaQor primarily targets physician groups, facilities and associations trying to acquire advocacy through the larger governing boards with a member-exclusive discount. The revenue streams of this social media platform would include freemium, premium subscription fees, sponsorship, talent search per individual/ facility, and so on. As LinkedIn has shown, there is a need for additional access, knowledge, and connectivity, which comes with a monthly premium access fee. In fact, LinkedIn’s data indicates that individuals are willing to spend $30, while corporations are willing to pay $60 for such services which means InnovaQor definitely can earn strong revenues from its niche. The Talent Search Subscription program is anticipated to upend the market by utilizing AI for matchmaking based on user profile optimization. The Talent Solutions feature on LinkedIn generates 65% of the company's revenue, displacing market leaders like Monster and Indeed. With InnovaQor/Curallo employing an industry-specific model, TSSP is a boon for healthcare professionals, especailly in todays hiring market. Large pharma would find the platform to be alluring for advertising with an engaged industry audience as well. Thus, this new platform could be a huge revenue catalyst for InnovaQor.
ClinLab is a proprietary Windows-based, Internet and web-enabled laboratory information management system. Designed by medical technologists, ClinLab is scalable from small point-of-care labs to large multi-user, multi-location clinical facilities. ClinLab acts as a data warehouse for lab results and includes reporting, data acquisition, label printing, electronic signoff and provides numerous interface capabilities to a multitude of reference labs and practice systems.
Healthcare Technology Solutions (HTS) Virtual Chief Information Officer (vCIO) services provides one-stop, specialized IT services for healthcare facilities which enhance business operations and encourage sustainable growth. Our services focus on infrastructure-related management and we ensure you maintain a competitive advantage with innovative technology solutions. With HTS's vCIO services, organizations gain access to best-in-class managed IT and cloud solutions without the headaches of supporting an in-house staff.
Qira analytics integrates data across your entire business – streamlining operations that improve services, reporting and financial health.
MEDtuning delivers Personalized Medicine to modern clinical practices. MEDtuning develops revolutionary PhyzioType Systems for DNA-guided management and prescription of drugs used to treat mental illness, pain, heart disease, and diabetes. These systems are designed to provide physicians with an unprecedented capability to select for each patient the safest and most effective drug to achieve treatment goals and enhance patient compliance.
WEST PALM BEACH, Fla., Sept. 28, 2022 (GLOBE NEWSWIRE) -- InnovaQor, Inc. (OTC: VMCS), today announced that it became a fully SEC reporting company on September 27, 2022 when its Form 10-12G that was filed on September 7, 2022 became effective.
For more information:
https://www.innovaqor.com/
https://medicalmime.com/
https://healthtechnologysolutions.com/analytics/
https://healthtechnologysolutions.com/vcio-services/
https://clinlabinc.com/
https://www.otcmarkets.com/stock/VMCS/security
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |